Literature DB >> 12142122

Demographics and correlates of five-year change in echocardiographic left ventricular mass in young black and white adult men and women: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Julius M Gardin1, Debra Brunner, Pamela J Schreiner, Xiaoyuan Xie, Cheryl L Reid, Karen Ruth, Diane E Bild, Samuel S Gidding.   

Abstract

OBJECTIVE: The goal of this study was to determine the presence and correlates of change (Delta) in left ventricular (LV) mass by echocardiography in young adults.
BACKGROUND: Left ventricular mass is known to be a powerful independent predictor for cardiovascular disease events in adults. However, little is known about Delta in LV mass over time in young adults.
METHODS: Coronary Artery Risk Development in Young Adults (CARDIA) is a multicenter, longitudinal, population-based study of black and white men and women who were ages 23 to 35 at the time of their initial two-dimensionally directed M-mode echocardiography exam (year 5); half the cohort had a repeat echocardiography exam five years later (year 10). Data were analyzed from 1,189 participants who had paired echocardiography studies. To minimize reader variability, blinded measurements on initial and repeat echocardiography were performed nearly contemporaneously by the same reader.
RESULTS: In multilinear regression analyses, significant (p < 0.05) predictors of year 10 two-dimensional guided M-mode LV mass included initial LV mass, initial body mass index (BMI) and change in BMI for all race/gender subgroups. Initial systolic blood pressure (SBP) was a significant predictor of year 10 LV mass in white men and black women; change in SBP was significant in black women with a trend towards significance in white women. Left ventricular mass remained constant in all race/gender subgroups, except black women, where it increased (by 5.9 g [mean]). Black women also had the largest increases in BMI and SBP. In black women, a five-year weight gain of 20 pounds and a 15-mm Hg increase in SBP would be expected to be associated with a 9% to 12% increase in LV mass.
CONCLUSIONS: Particularly in black women, weight and blood pressure control may be important community health and treatment goals to prevent LV hypertrophy.

Entities:  

Mesh:

Year:  2002        PMID: 12142122     DOI: 10.1016/s0735-1097(02)01973-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  30 in total

1.  Relationship between left ventricular mass and coronary artery disease in young adults: a single-center study using cardiac computed tomography.

Authors:  Jae Yong Cho; Joo Sung Sun; Young Keun Sur; Jin Sun Park; Doo Kyoung Kang
Journal:  Int J Cardiovasc Imaging       Date:  2015-10-01       Impact factor: 2.357

2.  Low cardiovascular risk is associated with favorable left ventricular mass, left ventricular relative wall thickness, and left atrial size: the CARDIA study.

Authors:  Samuel S Gidding; Mercedes R Carnethon; Stephen Daniels; Kiang Liu; David R Jacobs; Steve Sidney; Julius Gardin
Journal:  J Am Soc Echocardiogr       Date:  2010-07-01       Impact factor: 5.251

3.  Framingham score and LV mass predict events in young adults: CARDIA study.

Authors:  Anderson C Armstrong; David R Jacobs; Samuel S Gidding; Laura A Colangelo; Ola Gjesdal; Cora E Lewis; Kirsten Bibbins-Domingo; Stephen Sidney; Pamela J Schreiner; O D Williams; David C Goff; Kiang Liu; Joao A C Lima
Journal:  Int J Cardiol       Date:  2014-01-16       Impact factor: 4.164

4.  Racial/ethnic differences in the prognostic utility of left ventricular mass index for incident cardiovascular disease.

Authors:  Emmanuel Akintoye; Karim Mahmoud; Mohamed Shokr; Aubin Sandio; Sagar Mallikethi-Reddy; Muhammad Sheikh; Oluwole Adegbala; Alexander Egbe; Alexandros Briasoulis; Luis Afonso
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

5.  Quality Control and Reproducibility in M-Mode, Two-Dimensional, and Speckle Tracking Echocardiography Acquisition and Analysis: The CARDIA Study, Year 25 Examination Experience.

Authors:  Anderson C Armstrong; Erin P Ricketts; Christopher Cox; Paul Adler; Alexander Arynchyn; Kiang Liu; Ellen Stengel; Stephen Sidney; Cora E Lewis; Pamela J Schreiner; James M Shikany; Kimberly Keck; Jamie Merlo; Samuel S Gidding; João A C Lima
Journal:  Echocardiography       Date:  2014-11-09       Impact factor: 1.724

Review 6.  LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice.

Authors:  Anderson C Armstrong; Samuel Gidding; Ola Gjesdal; Colin Wu; David A Bluemke; João A C Lima
Journal:  JACC Cardiovasc Imaging       Date:  2012-08

7.  Trajectories of Childhood Blood Pressure and Adult Left Ventricular Hypertrophy: The Bogalusa Heart Study.

Authors:  Tao Zhang; Shengxu Li; Lydia Bazzano; Jiang He; Paul Whelton; Wei Chen
Journal:  Hypertension       Date:  2018-05-21       Impact factor: 10.190

8.  Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities study.

Authors:  Amil M Shah; Susan Cheng; Hicham Skali; Justina Wu; Judy R Mangion; Dalane Kitzman; Kunihiro Matsushita; Suma Konety; Kenneth R Butler; Ervin R Fox; Nakela Cook; Hanyu Ni; Josef Coresh; Thomas H Mosley; Gerardo Heiss; Aaron R Folsom; Scott D Solomon
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-08       Impact factor: 7.792

9.  Sedentary screen time and left ventricular structure and function: the CARDIA study.

Authors:  Bethany Barone Gibbs; Jared P Reis; Erik B Schelbert; Lynette L Craft; Steve Sidney; Joao Lima; Cora E Lewis
Journal:  Med Sci Sports Exerc       Date:  2014-02       Impact factor: 5.411

10.  Weight loss and progressive left ventricular remodelling: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Ravi V Shah; Venkatesh L Murthy; Siddique A Abbasi; John Eng; Colin Wu; Pamela Ouyang; Raymond Y Kwong; Allison Goldfine; David A Bluemke; Joao Lima; Michael Jerosch-Herold
Journal:  Eur J Prev Cardiol       Date:  2014-07-09       Impact factor: 7.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.